Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.
-- Earned a $68M milestone payment from Kite for iMMagine-1 enrollment -- -- Submitted an abstract for the iMMagine-1 study at the 66th ASH Annual Meeting -- -- The global Phase 3 trial...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 5.65 | 7.15642811906 | 78.95 | 88.66 | 77.99 | 758545 | 84.89319543 | CS |
4 | 13.36 | 18.7535092645 | 71.24 | 88.66 | 64.1 | 503394 | 77.10952167 | CS |
12 | 30.91 | 57.571242317 | 53.69 | 88.66 | 49 | 452668 | 66.78933653 | CS |
26 | 13.58 | 19.1213742608 | 71.02 | 88.66 | 47.88 | 458386 | 60.29044666 | CS |
52 | 50.7 | 149.557522124 | 33.9 | 88.66 | 30.88 | 528337 | 55.56127122 | CS |
156 | 65.6 | 345.263157895 | 19 | 88.66 | 6.035 | 470681 | 39.70629392 | CS |
260 | 65.6 | 345.263157895 | 19 | 88.66 | 6.035 | 470681 | 39.70629392 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.